Noninvasive Quantification of Local Cerebral Metabolic Rate of Glucose for Clinical Application Using Positron Emission Tomography and 18 F-Fluoro-2-Deoxy- d -Glucose
Until now, input function is still required in quantification of local cerebral metabolic rate of glucose (LCMRGlc) using positron emission tomography (PET) and 18F-fluoro-2-deoxy-d-glucose (FDG). Some image-derived methods were developed to get input function noninvasively instead of the arterial blood sampling method, but they needed to make complicated corrections manually, so they cannot always be applied in clinic directly. Here, we propose a simple method based on the Patlak approach by using a reference tissue region and without using any information of input function. This simulation study revealed that the present method was in good agreement with Patlak method; the difference between two methods was less than 5%. The statistical errors with two methods were also obtained, and the results showed the accuracy of LCMRGlc estimated with present method was better than that with Patlak method slightly. The simulation results indicated that the calculation of LCMRGlc with present method was quite stable and independent of the choosing of reference tissue region. All of these show that the present method is a good approximation to Patlak method. The calculation with this method is very simple and easy to perform voxel by voxel; therefore, it can be widely used not only in laboratory studies but also in clinical applications although it only provides the relative rates.
Local cerebral metabolic rate of glucose (LCMRGlc) is an important index to embody the neural function, using 18F-fluoro-2-deoxy-D-glucose (FDG), as the tracer with positron emission tomography (PET) becomes one of the most widely used noninvasive methods for quantification of LCMRGlc in humans (Phelps et al, 1979; Reivich et al, 1979). In quantification of LCMRGlc with PET/FDG, the plasma time—activity curve (PTAC) is required and used as the input function. In the early studies, the PTACs are usually obtained by taking arterial or arterialized venous blood samples invasively (Phelps et al, 1979; Huang et al, 1980). The arterial blood sampling needs inserting arterial lines; it is quite invasive and causes the patient discomfort, involves potential risks of arterial thrombosis, arterial sclerosis, and ischemia to the distal extremity (Chen et al, 1998). The acquirement and processing of arterial blood is also incompatible in the PET study or its clinical application; it requires extra personnel to process, exposes personnel to the risks associated with the handling of patient blood and increased radiation from proximity to the patient (Correia, 1992), and needs additional laboratory procedures for measuring the blood samples and calibrating the equipment. This kind of LCMRGlc quantification is not always performed in PET/FDG practices.
Owing to the disadvantages associated with the arterial or arterialized blood samples, some methods have been developed to minimize or eliminate the invasive blood sampling procedure in PET studies of brain and other organs. Most of the useful methods are using the time—activity curve obtained from an region of interest (ROI) drawn on the vascular structure over the PET images as the input function, therefore this kind of input function is also named as the image-derived input function (Chen et al, 1998). These techniques are well used in cardiac PET studies (Weinberg et al, 1988; Gambhir et al, 1989; Iida et al, 1992), hepatic and renal PET studies (Germano et al, 1992; Chen et al, 1992), and brain PET studies (Chen et al, 1998; Parker and Feng, 2005), in which the input functions are obtained by selecting an ROI within the cavity of the left ventricle, the abdominal aorta, and the internal carotid arteries, respectively. However, when the tracer starts gathering in the adjacent tissue, the spillover from tissue-to-blood aggravates and should be corrected. The partial volume effects induced by the small size of these ROI should also be raveled out. In correcting spillover and partial volume effects, some venous blood samples are still required. Owing to the PET data itself and the need to make corrections for above effects, the input functions obtained with these methods are extremely noisy; therefore, the direct use of such input functions in FDG dynamic model increases the statistical uncertainties in the estimated model parameters such as LCMRGlc (Lin et al, 1992). As the complete time course of the input function is needed in making above corrections and the input function changes immediately in the early stage after the bolus tracer injection, it needs a fast image-acquisition protocol and causes added manipulations.
To solve the problems with the image-derived input function, an analytical model of the input function (Feng et al, 1993; Phillips et al, 1995) or a template calculated from a sample population (Takikawa et al, 1993) was applied. Because these PTAC models were based on other FDG experimental data obtained from blood samples of the population, the input function of single subject can be determined by estimating a few model parameters. With the template, the input function of single subject can be replaced by that of the population. However, because there are many differences in individual physiologic states (e.g., cardiac output) and procedural factors (e.g., the injection rate), it is hard to use a simple model or uniform pattern to describe the shape of the input function. As the modeling method still needs some blood samples of the subject to estimate PTAC parameters, and the sampling number depends on the parameter number, more reliable model needs more parameters. Therefore if one has to get true input function, this method cannot reduce the blood sampling number drastically. In addition, the template may also not match well with special data of the patient. Therefore, all the methods including arterial blood sampling, image-derived, and modeling (or template) method for input function cannot simply be used to quantify LCMRGlc in clinical case.
Because the input function is a common factor for the tissue time—activity curve (TTAC, also defined as output function) in tracer dynamic models, it is assumed that the input function is uniform for all TTACs in different regions of brain. Therefore using multiequations for TTACs of these different regions, this common factor can be removed and the model parameters can be estimated without using the input function. This method has been applied successfully in quantification of the cerebral blood flow using PET with 15O-water (Mejia et al, 1994; Watabe et al, 1996), whose kinetics is described by a single-compartment model. Because the kinetics of FDG is more complex than that of 15O-water, this method cannot be used for FDG directly. However by considering Patlak graphical approximation (Patlak et al, 1983; Patlak and Blasberg, 1985) we propose a similar approach for the quantification of LCMRGlc with PET/FDG. The method uses two TTACs from two different regions and is noninvasive completely. It requires neither arterial blood, nor corrections for the spillover and partial volume when using image-derived input function. Unlike methods using an arterial input function, only the relative net FDG clearance can be estimated using the present method without other constraints. However, even after removing the global effect, this method will still be able to produce functional images of LCMRGlc pixel by pixel with short calculation times, and can also be carried out automatically without needing manual operation. 18F-Fluoro-2-deoxy-d-glucose is commonly used with PET to image metabolic states for diagnosis of brain and heart disease as well as cancer and other disease. The accuracy of clinical diagnosis depends on whether and how the PET data are quantified to the physiologic value. Therefore this method can also be used for the daily clinical diagnosis instead of using tissue radioactivity or its homomorphism—standard uptake value.
Theory
The present method is based on the Patlak graphical approach (Patlak et al, 1983; Patlak and Blasberg, 1985), in which the relationship between tissue radioactivity concentration and arterial input function can be described as follows:
where ci*(t) and Cp*(t), respectively, reflect the radioactive FDG concentrations at time t in the brain tissue and arterial blood, K is the net FDG clearance from blood to tissue (Kuwabara et al, 1990) and is used to calculate LCMRGlc (R = (cp/LC)K, where cp is the glucose concentration in the plasma, LC is the lumped constant, which summarizes the difference between FDG and glucose in transportation and phosphorylation) (Sokoloff et al, 1977; Huang et al, 1980), W is another constant related to the steady-state volume of the reversible compartments and effective plasma volume (Patlak and Blasberg, 1985). Both ci*(t) and cp*(t) are decay-corrected.
Arbitrarily choosing two regions called reference region and objective region in brain (or other organs), equation (1) can be described for both regions as follows:
where the subscript ‘r’ and ‘o’ denote the reference region and objective region, respectively. It is assumed that the input function cp*(t) is same for all regions in brain.
where t0 is the time of the first used frame for PET scan after FDG injection. Recall that the equation (1) is an approximation to the FDG dynamic model (see Materials and methods) in the time region greater than t0, where t0 is approximately 10 mins; therefore all equations derived from equation (1) is also approximate and validated in the time region greater than t0 only. To simplify the expression, ‘t > t0‘ will be ignored in subsequent equations concerning to this.
In equations (4) and (5), the arterial input function cp*(t) has been eliminated. Denoting Kor = Ko/Kr (the relative net FDG clearance in objective region to reference region), Wrr = Wr/Kr and Wor = Wo/Kr, equation (5) can be rewritten simply as
Taking digitized samples at time t0, t1,…, tn (t0, t1,…, tn are the sampling times of PET scans used), n equations based on equation (6) are obtained
where ε1, ε2,…, εn are the equation error terms. Because the integration term of ci*(t) exists in equation (7), the errors of these equations are not independent of each other even though the measurement errors of ci*(t) are independent. They are a set of linear equations about three parameters of Kor, Wrr, and Wor. Let
Equation (7) can be rearranged into a matrix form:
Therefore the parameters Kor, Wrr, and Wor will be estimated easily and quickly from equation (8) using linear least-squares method
In equation (9), no information regarding input function was needed. Although Kor is defined in the ROI, it can also be calculated pixel by pixel if a pixel is selected as an ROI. It is worth mentioning here that using equations (2) and (3), Ko, Wo, and Kr, Wr can be calculated, respectively. As the comparison, Kor, Wrr, and Wor can be estimated with Patlak method too, but as described above, it needs input functions.
Materials and methods
To reflect the real situation, TTACs ci*(t) were generated using three-compartmental model (equation (10)), the FDG dynamic model (Huang et al, 1980):
where ⊗ denotes operation of convolution,
k1*, k2*, k3*, and k4* are the transport rate constants, and cp*(t) is the input function.
In this computer simulation study, a PTAC model was used to generate the input function curve. We used the following equation, proposed in Feng et al (1993), to generate the plasma time—activity input function, cp*(t):
where λ1, λ2, and λ3 are the eigenvalues and A1, A2, and A3 are the coefficients of the model. A typical cp*(t) is shown in Figure 1 using the following values: A1 = 851.1225, A2 = 20.8113, and A3 = 21.8798 (μCi/mL), and λ1 = −4.133859, λ2 = −0.01043449, and λ3 = −0.1190996 (min−1). As these coefficient values and eigenvalues are derived from real FDG PTAC input function studies (Feng et al, 1993), this input function reflects also the real situation.
Typical plasma time-activity curve. The horizontal axis is time in minutes. The vertical axis is the radioactivity in μCi/mL.
To simulate the real situation, the pseudorandom number of the rate constants k1*, k2*, k3*, and k4* were generated with continuous uniform distribution, in which the interval of each constant were taken as 0.015 < k1* < 0.286, 0.024 < k2* < 0.546, 0.010 < k3* < 0.192, and 0.0014 < k4* < 0.0186. They are based on the experimental results of Huang et al (1980) for both grey and white matters in human brain from 13 subjects. The upper limits of these rate constants were double their maximum values in the literature (Huang et al, 1980) and the lower limits were half their minimum values. The TTACs were calculated using equation (10) by using the above cp*(t) values, above random rate constants and other four sets of typical transport rate constants obtained in human study (Hawkins et al, 1986), as shown in Table 1.
Four sets of fixed rate constants in simulation study
ROI #
Structure
Rate constant
k1* (ml/min per g)
k2* (min−1)
k3* (min−1)
k4* (min−1)
1
Grey matter
0.041
0.119
0.064
0.0075
2
White matter
0.023
0.073
0.034
0.0098
3
Tumor
0.028
0.087
0.047
0.0084
4
Whole brain
0.034
0.112
0.061
0.0098
In this study, because the proposed method does not use the input function, and only the effects of PET measurement noise was considered, we did not add any errors to input function in the Patlak method as comparison. The Gaussian noises were added on TTACs using a pseudorandom number generator, in which the mean value of random number was zero and the error variance was calculated from the following equation (Feng et al, 1995):
where α is the noise level and was set to 0 (noise-free), 0.1, 0.5, 1.0, 2.0, and 4.0, respectively; c−i* (t′j) = ∫tj-1tjci* (τ) dτ/δtj is the average value of ci*(t) over the length of the jth scanning interval, t′j = (tj–1 + tj)/2 and δtj = tj–tj–1 is the length of jth scanning interval.
Results
We defined five kinds of ROI in Materials and methods, one of them is generated with FDG dynamic model using the random rate constants k and denoted by subscript p. The rate constants k in this kind of ROI were taken randomly and used to represent different tissue (because we did not perform the real PET experiment, we require this kind of ROI to reflect the real situation). Other four ROIs are generated using four sets of fixed rate constants k listed in Table 1 and denoted by their ROI# as the subscript, they play the role of reference region to first kind of ROI or themselves. As the first and last subscripts of K also denote the objective region and reference region, respectively, Kij (i, j = 1, 2, 3, 4, i ≠ j) indicates the relative net FDG clearance in ROI #i to ROI #j and Kpi (i = 1, 2, 3, 4) indicates the relative net FDG clearance in the ROI generated with random rate constants to the ROI #i. Five thousand event data for each set of TTACs were generated with each noise level. Finally there are 5 × 6 groups data set. For each TTAC, there were 11 scanning intervals starting from 5 mins after FDG injection, and each frame lasted 5 mins.
To check the correlation between different calculations of Kor (the relative net FDG clearance), the linear regression y = Sx + I was carried out using weighted least-squares method, in which the weight was taken as (x2 + y2), where y and x are the two Kor values calculated using two methods, S is the slope and I is the intercept. Figure 2 is an example of the correlation between two values of Kp1 estimated with Patlak method and the present method with noise level α = 1.0. Similar results were obtained and are shown in Table 2 for other such comparisons. Table 2 gives the slope, intercept, and correlation coefficient (R) for the comparison between Patlak and the present methods with six different noise levels. The slopes are close to unity, the intercepts are close to 0, and the correlation coefficients are very close to 1; this implies that the two methods are very similar. As mentioned above, the Patlak method is an approximation to the FDG dynamic model; the present and Patlak method are also not equivalent exactly for real FDG data. Therefore even in the absence of noise, there still exists small difference between the Kor values estimated using these two methods.
Comparison of the Patlak and the present methods
Noise level
Kp1
Kp2
Kp4
Slope
Intercept
R
Slope
Intercept
R
Slope
Intercept
R
0.0
1.0197
0.0204
0.9999
1.0742
0.0619
0.9998
1.0317
0.0311
0.9999
0.1
1.0158
0.0400
0.9997
0.9867
0.0892
0.9996
1.0076
0.0559
0.9997
0.5
1.0044
0.0678
0.9993
0.9560
0.1176
0.9993
0.9931
0.0831
0.9993
1.0
0.9909
0.0814
0.9989
0.9294
0.1381
0.9989
0.9730
0.1019
0.9989
2.0
0.9656
0.0994
0.9983
0.8905
0.1645
0.9982
0.9441
0.1198
0.9983
4.0
0.9303
0.1172
0.9972
0.8395
0.1952
0.9968
0.9058
0.1349
0.9972
The correlation of KP1 (ROI #1 is the reference region) calculated using the Patlak method (abscissa) and the present method (ordinate) with noise level α = 1.0. The white solid line among scattering dots is the regression line.
According to Kor = Ko/Kr and Kro = Kr/Ko, the product of these two parameters should be equal to 1. If objective and reference region are exchanged with each other in equation (6), two equations are obtained. If equation (6) is exact one, these two equations will be equivalent and this requirement will also be satisfied spontaneously, however, since equation (6) is only an approximate equation, Kor and Kro are two parameters estimated using present method from two different equations, they will not be always satisfied with this requirement. Kor and K−1ro (the inverse of Kro) have been compared. Figure 3 is an example of such correlation for Kp4 and K−14p with noise level α = 2.0. Similar results were obtained and are shown in Table 3 for other such comparisons. Figure 3 and Table 3 show that with six different noise levels the slope, intercept, and correlation coefficients are very close to 1, 0, and 1, respectively, which means irrespective of which ROIs is taken as reference region, the results estimated using the present method will still be very consistent.
Comparison of Kpi and the inverse of Kip (i = 1, 2, 4)
Noise level
Kp1 versus K−11p
Kp2 versus K−12p
Kp4 versus K−14p
Slope
Intercept
R
Slope
Intercept
R
Slope
Intercept
R
0.0
1.0013
0.0056
1.0000
1.0019
0.0012
1.0000
0.9986
–0.0035
1.0000
0.1
1.0034
0.0083
1.0000
1.0072
0.0018
1.0000
0.9956
–0.0070
1.0000
0.5
1.0065
0.0123
0.9999
1.0132
0.0032
1.0000
0.9904
–0.0093
1.0000
1.0
1.0096
0.0114
0.9999
1.0189
0.0018
1.0000
0.9864
–0.0081
1.0000
2.0
1.0137
0.0106
0.9999
1.0255
0.0015
0.9999
0.9815
–0.0078
0.9999
4.0
1.0213
0.0071
0.9999
1.0307
0.0061
0.9999
0.9735
–0.0062
0.9999
The correlation of Kp4 and K−14p with noise level α = 2.0. The white solid line among scattering dots is the regression line.
Defining . However, like Kor and K−1ro, rKij is not always equal to Kij when using the present method to estimate them. Figure 4 is an example of such a correlation for Kp2 and rKp2 with noise level α = 4.0. Similar results were obtained and are shown in Table 4 for other such comparisons. Figure 4 and Table 4 show that with six different noise levels, the slope, intercept, and correlation coefficients are also very close to 1, 0, and 1, respectively, this also means present method is a very consistent one.
Comparison of Kpi and rKpi (i = 1, 2, 4)
Noise level
KpI versus rKp1
Kp2 versus rKp2
Kp4 versus rKp4
Slope
Intercept
R
Slope
Intercept
R
Slope
Intercept
R
0.0
0.9238
0.0041
1.0000
1.0213
–0.0094
0.9999
0.9739
0.0076
0.9999
0.1
1.0017
0.0052
1.0000
0.9802
–0.0043
1.0000
1.0176
0.0042
1.0000
0.5
1.0012
0.0015
0.9999
0.9813
0.0068
0.9999
1.0138
–0.0025
0.9999
1.0
0.9993
0.0012
0.9998
0.9796
0.0104
0.9998
1.0131
–0.0041
0.9998
2.0
0.9982
–0.0006
0.9998
0.9804
0.0105
0.9997
1.0091
–0.0030
0.9998
4.0
0.9953
0.0003
0.9997
0.9854
0.0031
0.9997
1.0006
0.0038
0.9997
The correlation of Kp2 and rKp2 with very high noise level α = 4.0. The white solid line among scattering dots is the regression line.
Using the four set of TTACs generated with fixed rate constants listed in Table 1, the difference between two Kor (o, r = 1, 2, 3, 4, o > r) values estimated with the Patlak method and the present method as well as their relative errors were got. The simulation results show that Kor obeys Gaussian distribution; by fitting line shapes of their distributions, the mean, and standard error were derived. Figure 5 shows that up to very high noise level (α = 4.0) the ratios of Kor estimated using the two methods are still close to 1 and the relative differences are less than 5%. Figure 6 shows that the relative errors with two methods changed increasingly with noise level, but the errors using the present method was less than those with the Patlak method. This indicates that the present method is a good approximation to Patlak method.
The ratios of Kor (o, r = 1, 2, 3, 4, o > r) values estimated by using the Patlak and the present methods against the noise level.
The relative errors changed with noise level for Kor (o, r = 1, 2, 3, 4, o > r) estimated by using (A) the present method and (B) the Patlak method. —▢—, K21;—○—, K31; — × —, K41; — + —, K32; —⋆—, K42; — □ —, K43.
Discussion and Conclusion
The above results show that the relative net FDG clearance in one ROI compared to the other can beestimated using the present method as a good approximation to the Patlak approach. Without other constraints, the absolute value of net FDG clearance cannot be calculated using the present method, this is the main drawback of this kind of reference method. In Watabe et al (1996), a quantitative absolute blood flow was estimated under the constraint that the distribution volume of water for all pixels within 10% of the maximum counts was fixed to 0.86 ml/ml. This assumption might be reasonable, but when comparing mean regional cerebral blood flow values of 17 subjects calculated using the dynamic/integral method and their method, the disagreement between the two methods in the high-flow study is not too small; this might be induced by the above assumption.
As the ROI is chosen as reference is not important in the present method, the simple way is to allow the whole brain (e.g., ROI#4 listed in Table 1) as the reference ROI. According to Sokoloff et al (1977) and Huang et al (1980), the LCMRGlc is
the global metabolic rate of glucose (GCMRGlc) is equal to Rg = (cp/LC)Kg, where cp is the glucose concentration in the plasma, LC is the lumped constant, and K and Rg are the net FDG clearances in local area and whole brain, respectively. Assuming LC is uniform in brain, equation (13) becomes to
where K/Kg is the relative net FDG clearance in local area to whole brain and can easily estimated using present method. Equations (13) and (14) can be used to calculate the LCMRGlc: equation (13) requires constant parameter LC, cp, and net FDG clearance (K) in local area, and equation (14) requires constant parameter Rg and the relative net FDG clearance (K/Kg) in the local area to whole brain. To calculate K using other methods needs the input function, but to calculate K/Kg using present method does not.
Both measurements of the constant parameter LC and Rg are quite invasive and require other independent experiments. When calculating absolute LCMRGlc value derived from Patlak (or other methods using input function) and the present method, the universality of these constant parameters for the population is assumed. Generally speaking, this assumption is valid for healthy population. There may be some reasons to consider that the fluctuation of LC among the population is slightly lower than the fluctuation of Rg, but the measurement of LC also needs the measurement of Rg (Huang et al, 1980; Hasselbalch et al, 1998). Therefore it is difficult to say that the deviation of LC value is lower than the deviation of Rg value. In fact, the relative error of Rg shown in Hasselbalch et al (1998) is approximately 18%, but the relative error of LC is slightly greater than this value. The constant cp is required in equation (13), which introduces another uncertainty to LCMRGlc, but equation (14) does not. From this point, the accuracy of LCMRGlc derived from equation (14) is not worse than that derived from equation (13). Because we can use only equation (14) to calculate absolute LCMRGlc with present method, to avoid the difference between using equations (13) and (14) in comparison of absolute values of LCMRGlc with the present method and the Patlak method, the absolute LCMRGlcs in grey matter, white matter, and tumor were calculated using equation (14) and are shown in Table 5. Here Rg is taken as 23 μmol/100 g per min (Hasselbalch et al, 1998). Similar to K/Kg, the relative differences between absolute LCMRGlcs using the two methods are also less than 5%.
Comparison of absolute LCMRGlc value estimated with two methods (in unit of μmol/100 g per min)
Noise level
R in grey matter
R in white matter
R in tumor
Present method
Patlak method
Present method
Patlak method
Present method
Patlak method
0.1
28.02
28.21
16.34
15.75
20.21
20.12
0.5
28.00
28.22
16.61
15.81
20.33
20.19
1.0
27.98
28.23
16.77
15.88
20.38
20.26
2.0
27.92
28.24
16.92
16.02
20.43
20.40
4.0
27.78
28.25
17.05
16.30
20.51
20.67
Similar to LC, the Rg value is quite disperse among different experiments and depends on the measurement methods; the values of Rg in human brain is from 23(Hasselbalch et al, 1998) to 30 μmol/100 g per min (Cohen et al, 1967; Takeshita et al, 1972), and the typical value of LC in human brain is from 0.42 (Phelps et al, 1979; Brooks et al, 1987; Kuwabara et al, 1990) to 0.80 (Hasselbalch et al, 1998). The measured accuracies of both Rg and LC are not very good, therefore the reliability of absolute LCMRGlc value calculated with PET is debatable and all of the known methods cannot yet calculate it very accurately. Usually, the relative value of LCMRGlc already reflects the physiologic or pathologic states quantitively, especially for single subject diagnosis. For the comparison between two different metabolic states of single subject or group study in neural function, the global effect can be removed using scaling or ANCOVA model (Kiebel and Homes, 2004). Adding these constants at present is not necessary. For those situations requiring absolute LCMRGlc value, we may add these constants, but we have to consider this discrepancy. Of course, absolute LCMRGlc value is very important, and how to measure this value noninvasively and accurately in humans requires further studies.
Another important factor to be discussed is the standardized uptake value. It is an index widely used in clinical FDG studies and diagnoses without requiring blood samples. The validity of standardized uptake value depends mainly on two important assumptions and approximations: one is that at the large time T (e.g., more than 45 mins after injection), free FDG is a small fraction of the total radioactivity in tissue and can be neglected; another is that the integral of the PTAC curve is proportional to the injected dose and inversely proportional to body weight or body surface area (Huang, 2000). However, these two assumptions are not always valid. Specially in regarding the progression of disease, standardized uptake value and net FDG clearance estimated with Patlak method give opposite conclusions for some patients. The discrepancies between these two indices are mainly affected by these two assumptions (Freedman et al, 2003). In addition, the recovery coefficient and partial volume effects still exist and they are hardly solved in calculating standardized uptake value (Keyes, 1995; Huang, 2000). Therefore its reliability is still somewhat controversial (Keyes, 1995; Huang, 2000), and its application as a quantitative index should be discouraged (Keyes, 1995). However like Patlak method (the gold standard), the present method is not limited with these factors.
This simulation study shows that the present method is a very consistent one and a good approximation to the Patlak method. This method does not need any information on input function nor requires arterial blood or corrections for the spillover and partial volume when using image-derived input function. Using this method, calculation is simple and easy to perform voxel by voxel, therefore it can be widely used to generate quantified LCMRGlc image not only in laboratory studies but also in clinical application instead of using standard uptake value.
Footnotes
Acknowledgements
We acknowledge the helpful discussions with Dr Patlak and Dr Huafeng Liu. We also thank two anonymous reviewers for their helpful and constructive suggestions.
References
1.
BrooksRAHatazawaJDi ChiroGLarsonSMFishbeinDS (1987) Human cerebral glucose metabolism determined by positron emission tomography: a revisit. J Cereb Blood Flow Metab7:427–32
2.
ChenBGermanoGHuangSCHawkinsRHansenHRobertMBuxtonDSchelbertHKurtzIPhelpsM (1992) A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. J Am Soc Nephrol3:1295–306
3.
ChenKBandyDReimanEHuangSCLawsonMFengDYunLSPalantA (1998) Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab18:716–23
4.
CohenPAlexanderFReivichMWollmanH (1967) Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J Appl physiol23:183–9
5.
CorreiaJ (1992) Editorial: a bloody future for clinical PET. J Nucl Med33:620–2
6.
FengDHuangSCWangX (1993) Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int J Biomed Comput32:95–110
7.
FengDKoDChenKWuLCWanJKLiuRSYehSH (1995) Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. IEEE Trans Med Imaging14:697–710
8.
FreedmanNMTSundaramSKKurdzielKCarrasquilloJAWhatleyMCarsonJMSellersDLibuttiSKYangJCBacharachSL (2003) Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med30:46–53
9.
GambhirSSchwaigerMHuangSCKrivokapichJSchelbertHNienaberCPhelpsM (1989) Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med30:359–66
10.
GermanoGChenBHuangSCGambhirSHoffmanEPhelpsM (1992) Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med33:613–20
11.
HasselbalchSMadsenPKnudsenGHolmSPaulsonO (1998) Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans. J Cereb Blood Flow Metab18:154–60
12.
HawkinsRPhelpsMHuangSC (1986) Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood—brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET. J Cereb Blood Flow Metab6:170–83
13.
HuangSC (2000) Anatomy of SUV. Nucl Med Biol27:643–6
14.
HuangSCPhelpsMHoffmanESiderisKSelinCKuhlD (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol238:E69–82
15.
IidaHRhodesCde SilvaRAraujoLBloomfieldPLammertsmaAJonesT (1992) Use of the left ventricular time activity curve asa noninvasive input function in dynamic oxygen-15 water positron emission tomography. J Nucl Med33:1669–77
16.
KeyesJWJ (1995) SUV: standard uptake or silly useless value?J Nucl Med36:1836–9
17.
KiebelSHomesA (2004) The general linear model. In: Human brain function (FrackowiakRFristonKFrithCDolanRZekiSPriceC, eds), 2nd ed.San Diego, CA: Elsevier, 15–6
LinKPHuangSCChoiYBrunkenRSchelbertHPhelpsE (1992) A method for correction myocardium to blood pool spillover in dynamic cardiac PET FDG studies. J Nucl Med33:882
20.
MejiaMItohMWatabeHFujiwaraTNakamuraT (1994) Simplified nonlinearity correction of oxygen-15-water regional cerebral blood flow images without blood sampling. J Nucl Med35:1870–7
21.
ParkerBFengD (2005) Graph-based Mumford—Shah segmentation of dynamic PET with application to input function estimation. IEEE Trans Nucl Sci52:79–89
22.
PatlakCBlasbergR (1985) Graphical evaluation of blood to brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab5:584–90
23.
PatlakCBlasbergRFenstermacherJ (1983) Graphical evaluation of blood to brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab3:1–7
24.
PhelpsMHuangSCHoffmanESelinCSokoloffLKuhlD (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with F-18-2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol6:371–88
25.
PhillipsRLChenCYWongDFLondonED (1995) An improved method to calculate cerebral metabolic rates of glucose using PET. J Nucl Med36:1668–79
26.
ReivichMKuhlDWolfAGreenbergJPhelpsMIdoTCasellaVFowlerJHoffmanEAlaviASomPSokoloffL (1979) The 18-F-fluorodeoxyglucose method for the measurement of local cerebral glucose metabolism in man. Circ Res44:127–37
27.
SokoloffLReivichMKennedyCDes RosiersMPatlakCPettigrewKSakaduraOShinoharaM (1977) The C-14-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normalvalues in the conscious and anesthetized albino rat. J Neurochem28:897–916
28.
TakeshitaHOkudaYAtuoS (1972) The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology36:69–75
29.
TakikawaSDhawanVSpetsierisPRobesonWChalyTDahlRMargouleffDEidelbergD (1993) Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology188:131–6
30.
WatabeHItohMCunninghamVLammertsmaABloomfieldPMejiaMFujiwaraTJonesAKPJonesTNakamuraT (1996) Noninvasive quantification of rCBF using positron emission tomography. J Cereb Blood Flow Metab16:311–9
31.
WeinbergIHuangSCHoffmanEAraujoLNienaberCGrover-McKayMDahlbomMSchelbertH (1988) Validation of PET-acquired input functions for cardiac studies. J Nucl Med29:241–7